Rachael Windsor
Overview
Explore the profile of Rachael Windsor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taylor R, Purnell S, Hocking S, Windsor R, Gerrand C, Jenney M, et al.
J Patient Rep Outcomes
. 2025 Mar;
9(1):30.
PMID: 40067547
Purpose: Sarcomas account for approximately 10-15% of all cancer in children aged ≤ 16. Poorer health-related quality of life (HRQoL) is recorded in comparison to other cancers; however, these studies...
2.
Choderlos de Laclos X, Risbourg S, Brennan B, Bertucci F, Gaspar N, Gelderblom H, et al.
Eur J Cancer
. 2024 Jul;
208:114229.
PMID: 39032218
Introduction: Ewing sarcoma (ES), is a rare cancer affecting children, adolescents and adults. After VIDE (vincristine-ifosfamide-doxorobucin-etoposide) induction chemotherapy, Busulfan-Melphalan (BuMel) high-dose chemotherapy followed by autologous hematopoietic stem cells transplantation improved...
3.
Tatsis D, Sinha D, Le Grange F, Jay A, Salli M, Sadeghian G, et al.
Eur J Surg Oncol
. 2024 Jul;
50(9):108531.
PMID: 38996585
Objective: Globally, head & neck sarcoma care pathways remain unclear. In 2018, the London Sarcoma Service (LSS) set up a dedicated head and neck sarcoma (HNS) multidisciplinary team (MDT) with...
4.
Hulbert-Williams L, Hulbert-Williams N, Martins A, Storey L, Bradley J, OSullivan H, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539431
The Sarcoma Assessment Measure (SAM) was developed as a sarcoma-specific patient-reported outcome measure to be used in clinical practice. We have reported in detail how SAM has been developed in...
5.
Martin S, Clark S, Gerrand C, Gilchrist K, Lawal M, Maio L, et al.
Cancers (Basel)
. 2023 Aug;
15(15).
PMID: 37568761
Aims: To describe patients' experiences of pre-diagnostic signs/symptoms and pathways to diagnosis, including where help was sought, and the processes involved. Methods: Mixed methods involving quantitative, qualitative and inductive thematic...
6.
Petrella A, Storey L, Hulbert-Williams N, Fern L, Lawal M, Gerrand C, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765920
Fear of cancer recurrence (FCR) is a persistent concern among those living with cancer and is associated with a variety of negative psychosocial outcomes. However, people with sarcoma have been...
7.
Martins A, Bennister L, Fern L, Gerrand C, Onasanya M, Storey L, et al.
Cancer Nurs
. 2022 Dec;
47(2):84-92.
PMID: 36480349
Background: Treatment of soft tissue sarcoma frequently involves extensive surgery, loss of mobility, and complex rehabilitation programs. Poorer patient-reported outcomes are reported in comparison to those from patients with other...
8.
Hurkmans E, Koenderink J, van den Heuvel J, Versleijen-Jonkers Y, Hillebrandt-Roeffen M, Groothuismink J, et al.
Front Pharmacol
. 2022 Nov;
13:1042989.
PMID: 36438828
Despite (neo) adjuvant chemotherapy with cisplatin, doxorubicin and methotrexate, some patients with primary osteosarcoma progress during first-line systemic treatment and have a poor prognosis. In this study, we investigated whether...
9.
Windsor R, Hamilton A, McTiernan A, Dileo P, Michelagnoli M, Seddon B, et al.
Eur J Cancer
. 2022 May;
170:131-139.
PMID: 35635934
Background: outcome of primary refractory or recurrent Ewing sarcoma (RRES) is poor and the role of high-dose therapy (HDT) remains uncertain. We retrospectively reviewed all patients treated for RRES in...
10.
Meijer A, van den Heuvel-Eibrink M, Brooks B, Am Zehnhoff-Dinnesen A, Knight K, Freyer D, et al.
JAMA Oncol
. 2021 Aug;
7(10):1550-1558.
PMID: 34383016
Importance: Ototoxicity is an irreversible direct and late effect of certain childhood cancer treatments. Audiologic surveillance during therapy as part of the supportive care pathway enables early detection of hearing...